Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer

NCT00780169 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: sorafenib + FOLFIRI

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]